Secretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a transglutaminase substrate

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Baranger, Kévin ^a   Zani, Marie Louise ^a   Labas, Valérie ^b   Dallet Choisy, Sandrine ^a   Moreau, Thierry ^a  

^a UNIVERSITÉ DE TOURS   (France)

^b CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13; CADAVERINE; CATHEPSIN G; ELAFIN; ELASTASE; ELASTIN; FIBRONECTIN; GLUTAMINE; LEUKOCYTE ELASTASE; LEUKOCYTE ELASTASE INHIBITOR; LYSINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TRAPPIN 2; UNCLASSIFIED DRUG; BLOOD CLOTTING FACTOR 13A; DANSYLCADAVERINE; DRUG DERIVATIVE; GUANINE NUCLEOTIDE BINDING PROTEIN; PEPTIDE FRAGMENT; PI3 PROTEIN, HUMAN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SLPI PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; COVALENT BOND; MASS SPECTROMETRY; PROTEIN CROSS LINKING; PROTEIN DOMAIN; PROTEIN MODIFICATION; TRANSGLUTAMINATION; AMINO ACID SEQUENCE; ANIMAL; CATTLE; CHEMISTRY; GUINEA PIG; HUMAN; METABOLISM; MOLECULAR GENETICS; PROTEIN BINDING; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; CADAVERINE; CATTLE; ELAFIN; FACTOR XIIIA; FIBRONECTINS; GLUTAMINE; GTP-BINDING PROTEINS; GUINEA PIGS; HUMANS; LYSINE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN BINDING; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; SEQUENCE HOMOLOGY, AMINO ACID; TRANSGLUTAMINASES;

EID: 79958145057     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020976     Document Type: Article

References (32)

1. Korkmaz B, Horwitz MS, Jenne DE, Gauthier F, (2010) Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol Rev 62: 726-759.
2. Moreau T, Baranger K, Dade S, Dallet-Choisy S, Guyot N, et al. (2008) Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family. Biochimie 90: 284-295.
3. Guyot N, Zani ML, Berger P, Dallet-Choisy S, Moreau T, (2005) Proteolytic susceptibility of the serine protease inhibitor trappin-2 (pre-elafin): evidence for tryptase-mediated generation of elafin. Biol Chem 386: 391-399.
4. Nara K, Ito S, Ito T, Suzuki Y, Ghoneim MA, et al. (1994) Elastase inhibitor elafin is a new type of proteinase inhibitor which has a transglutaminase-mediated anchoring sequence termed "cementoin". J Biochem 115: 441-448.
5. Esposito C, Caputo I, (2005) Mammalian transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance. FEBS J 272: 615-631.
6. Molhuizen HO, Alkemade HA, Zeeuwen PL, de Jongh GJ, Wieringa B, et al. (1993) SKALP/elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking. J Biol Chem 268: 12028-12032.
7. Muto J, Kuroda K, Wachi H, Hirose S, Tajima S, (2007) Accumulation of elafin in actinic elastosis of sun-damaged skin: elafin binds to elastin and prevents elastolytic degradation. J Invest Dermatol 127: 1358-1366.
8. Guyot N, Zani ML, Maurel MC, Dallet-Choisy S, Moreau T, (2005) Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase. Biochemistry 44: 15610-15618.
9. Steinert PM, Marekov LN, (1995) The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J Biol Chem 270: 17702-17711.
10. Zani ML, Baranger K, Guyot N, Dallet-Choisy S, Moreau T, (2009) Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteases. Protein Sci 18: 579-594.
11. Lorand L, Parameswaran KN, Velasco PT, (1991) Sorting-out of acceptor-donor relationships in the transglutaminase-catalyzed cross-linking of crystallins by the enzyme-directed labeling of potential sites. Proc Natl Acad Sci U S A 88: 82-83.
12. Sugimura Y, Hosono M, Wada F, Yoshimura T, Maki M, et al. (2006) Screening for the preferred substrate sequence of transglutaminase using a phage-displayed peptide library: identification of peptide substrates for TGASE 2 and Factor XIIIA. J Biol Chem 281: 17699-17706.
13. Schalkwijk J, Wiedow O, Hirose S, (1999) The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core. Biochem J 340: 569-577.
14. Kamps JA, Te Boekhorst AH, Fransen JA, Ginsel LA, Dijkman JH, (1989) Antileukoprotease is associated with elastin fibers in the extracellular matrix of the human lung. An immunoelectron microscopic study. Am Rev Respir Dis 140: 471-476.
15. Wingens M, van Bergen BH, Hiemstra PS, Meis JF, van Vlijmen-Willems IM, et al. (1998) Induction of SLPI (ALP/HUSI-I) in epidermal keratinocytes. J Invest Dermatol 111: 996-1002.
16. Eisenberg SP, Hale KK, Heimdal P, Thompson RC, (1990) Location of the protease-inhibitory region of secretory leukocyte protease inhibitor. J Biol Chem 265: 7976-7981.
17. Kramps JA, van Twisk C, Appelhans H, Meckelein B, Nikiforov T, et al. (1990) Proteinase inhibitory activities of antileukoprotease are represented by its second COOH-terminal domain. Biochim Biophys Acta 1038: 178-185.
18. Parameswaran KN, Velasco PT, Wilson J, Lorand L, (1990) Labeling of epsilon-lysine crosslinking sites in proteins with peptide substrates of factor XIIIa and transglutaminase. Proc Natl Acad Sci U S A 87: 8472-8475.
19. Fesus L, Metsis ML, Muszbek L, Koteliansky VE, (1986) Transglutaminase-sensitive glutamine residues of human plasma fibronectin revealed by studying its proteolytic fragments. Eur J Biochem 154: 371-374.
20. Csosz E, Bagossi P, Nagy Z, Dosztanyi Z, Simon I, et al. (2008) Substrate preference of transglutaminase 2 revealed by logistic regression analysis and intrinsic disorder examination. J Mol Biol 383: 390-402.
21. Murthy SN, Lukas TJ, Jardetzky TS, Lorand L, (2009) Selectivity in the post-translational, transglutaminase-dependent acylation of lysine residues. Biochemistry 48: 2654-2660.
22. Wang Z, Wilhelmsson C, Hyrsl P, Loof TG, Dobes P, et al. (2010) Pathogen entrapment by transglutaminase-A conserved early innate immune mechanism. PLoS Pathog 6: e1000763.
23. Takahashi M, Tezuka T, Katunuma N, (1992) Phosphorylated cystatin alpha is a natural substrate of epidermal transglutaminase for formation of skin cornified envelope. FEBS Lett 308: 79-82.
24. Zeeuwen PL, Van Vlijmen-Willems IM, Jansen BJ, Sotiropoulou G, Curfs JH, et al. (2001) Cystatin M/E expression is restricted to differentiated epidermal keratinocytes and sweat glands: a new skin-specific proteinase inhibitor that is a target for cross-linking by transglutaminase. J Invest Dermatol 116: 693-701.
25. von Horsten HH, Johnson SS, SanFrancisco SK, Hastert MC, Whelly SM, et al. (2007) Oligomerization and transglutaminase cross-linking of the cystatin CRES in the mouse epididymal lumen: potential mechanism of extracellular quality control. J Biol Chem 282: 32912-32923.
26. Ritchie H, Lawrie LC, Crombie PW, Mosesson MW, Booth NA, (2000) Cross-linking of plasminogen activator inhibitor 2 and alpha 2-antiplasmin to fibrin(ogen). J Biol Chem 275: 24915-24920.
27. Hevessy Z, Patthy A, Karpati L, Muszbek L, (2000) alpha(2)-plasmin inhibitor is a substrate for tissue transglutaminase: an in vitro study. Thromb Res 99: 399-406.
28. Mortensen SB, Sottrup-Jensen L, Hansen HF, Rider D, Petersen TE, et al. (1981) Sequence location of a putative transglutaminase crosslinking site in human alpha 2-macroglobulin. FEBS Lett 129: 314-317.
29. Schmidt S, Adolf F, Fuchsbauer HL, (2008) The transglutaminase activating metalloprotease inhibitor from Streptomyces mobaraensis is a glutamine and lysine donor substrate of the intrinsic transglutaminase. FEBS Lett 582: 3132-3138.
30. Zani ML, Nobar SM, Lacour SA, Lemoine S, Boudier C, et al. (2004) Kinetics of the inhibition of neutrophil proteinases by recombinant elafin and pre-elafin (trappin-2) expressed in Pichia pastoris. Eur J Biochem 271: 2370-2378.
31. Higuchi R, Krummel B, Saiki RK, (1988) A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res 16: 7351-7367.
32. Schägger H, von Jagow G, (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166: 368-379.